Editorial: The crosstalk of different mechanisms in cognitive impairment associated with aging, Alzheimer's disease, and related dementias

Editorial: The crosstalk of different mechanisms in cognitive impairment associated with aging, Alzheimer's disease, and related dementias

Bibliographic Details
Main Author:	Lydia Giménez-Llort
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2023-08-01
Series:	Frontiers in Aging Neuroscience
Subjects:	Alzheimer's disease cognitive impairment crosstalk peripheral system clinical trials translational research
Online Access:	https://www.frontiersin.org/articles/10.3389/fnagi.2023.1258893/full

Similar Items

Crosstalk of Alzheimer’s disease-phenotype, HPA axis, splenic oxidative stress and frailty in late-stages of dementia, with special concerns on the effects of social isolation: A translational neuroscience approach
by: Aida Muntsant, et al.
Published: (2022-09-01)

Editorial: Pharmacology of BPSD (Behavioral and Psychological Symptoms of Dementia)
by: Lydia Giménez-Llort, et al.
Published: (2021-06-01)

Modeling Functional Limitations, Gait Impairments, and Muscle Pathology in Alzheimer’s Disease: Studies in the 3xTg-AD Mice
by: Lidia Castillo-Mariqueo, et al.
Published: (2021-10-01)

Cognitive Blackouts in Mild Cognitive Impairment and Alzheimer’s Dementia
by: Georg Adler, et al.
Published: (2018-02-01)

Sex-Dependent Hepatomegaly, and Increased Hepatic Oxidative Stress in Old Male and Female 3xTg-AD Mice as Compared to Mice with Physiological Aging
by: Juan Fraile-Ramos, et al.
Published: (2021-07-01)

Genotype Load Modulates Amyloid Burden and Anxiety-Like Patterns in Male 3xTg-AD Survivors despite Similar Neuro-Immunoendocrine, Synaptic and Cognitive Impairments
by: Aida Muntsant, et al.
Published: (2021-06-01)

Clinical Trials of New Drugs for Vascular Cognitive Impairment and Vascular Dementia
by: Tran Thanh Duy Linh, et al.
Published: (2022-09-01)

The Challenge of Subjective Cognitive Complaints and Executive Functions in Middle-Aged Adults as a Preclinical Stage of Dementia: A Systematic Review
by: Felipe Webster-Cordero, et al.
Published: (2022-03-01)

Digging Signatures in 13-Month-Old 3xTg-AD Mice for Alzheimer's Disease and Its Disruption by Isolation Despite Social Life Since They Were Born
by: Lydia Gimenez-Llort, et al.
Published: (2021-01-01)

Language in Amnestic Mild Cognitive Impairment and Dementia of Alzheimer’s Type: Quantitatively or Qualitatively Different?
by: Regina Jokel, et al.
Published: (2019-03-01)

Sex Differences in Demographic and Pharmacological Factors in Alzheimer Patients With Dementia and Cognitive Impairments
by: Oreoluwa O. Coker-Ayo, et al.
Published: (2022-04-01)

Muscle–Brain crosstalk in cognitive impairment
by: Xiaowei Han, et al.
Published: (2023-07-01)

Revisiting global cognitive and functional state 13 years after a clinical trial of lithium for mild cognitive impairment
by: Rodolfo Furlan Damiano, et al.
Published: (2023-03-01)

Relationship of Retinal Nerve Fibers Layer Thickness with Mild Cognitive Impairment and Alzheimer\'s Dementia
by: Siamak Akbarzadeh, et al.
Published: (2022-12-01)

Video feedback intervention for cognitively impaired older drivers: A randomized clinical trial
by: Brian R. Ott, et al.
Published: (2021-01-01)

Brief Report: Using the Internet to Identify Persons with Cognitive Impairment for Participation in Clinical Trials
by: Lindsay F. Morra, et al.
Published: (2017-04-01)

Observing Pain in Individuals with Cognitive Impairment: A Pilot Comparison Attempt across Countries and across Different Types of Cognitive Impairment
by: Miriam Kunz, et al.
Published: (2021-11-01)

Thigmotaxis Helps Differentiate Normal and Pathological Ageing Processes in a Mouse model of Alzheimer’s Disease
by: Daniel Alveal-Mellado, et al.
Published: (2021-07-01)

Cholinergic receptor binding in unimpaired older adults, mild cognitive impairment, and Alzheimer’s disease dementia
by: David L. Sultzer, et al.
Published: (2022-02-01)

Operationalizing selection criteria for clinical trials in Alzheimer's disease: Biomarker and clinical considerations
by: Ronald C. Petersen, et al.
Published: (2023-10-01)

Obesity, Impaired Glucose Metabolism and Hepatic Histopathological Damage in 3xTg-AD Mice at Different Stages of Disease Compared to Mice with Normal Aging
by: Clara Pérez-Gozalbo, et al.
Published: (2022-09-01)

Survival Bias, Non-Lineal Behavioral and Cortico-Limbic Neuropathological Signatures in 3xTg-AD Mice for Alzheimer’s Disease from Premorbid to Advanced Stages and Compared to Normal Aging
by: Aida Muntsant, et al.
Published: (2023-09-01)

Leukotriene receptor antagonist use and cognitive decline in normal cognition, mild cognitive impairment, and Alzheimer’s dementia
by: Lisa Y. Xiong, et al.
Published: (2021-09-01)

Benefits of Music Therapy in the Cognitive Impairments of Alzheimer’s-Type Dementia: A Systematic Review
by: María Jiménez-Palomares, et al.
Published: (2024-04-01)

Homocysteine – A predictor for five year-mortality in patients with subjective cognitive decline, mild cognitive impairment and Alzheimer's dementia
by: Ines Elisabeth Futschek, et al.
Published: (2023-02-01)

Attitudes toward clinical trials across the Alzheimer’s disease spectrum
by: Michelle M. Nuño, et al.
Published: (2017-10-01)

Plasma glial fibrillary acidic protein detects Alzheimer pathology and predicts future conversion to Alzheimer dementia in patients with mild cognitive impairment
by: Claudia Cicognola, et al.
Published: (2021-03-01)

Neuropsychiatric symptoms and mortality among patients with mild cognitive impairment and dementia due to Alzheimer's disease
by: Mei-Feng Huang, et al.
Published: (2022-09-01)

Facial emotion mimicry in older adults with and without cognitive impairments due to Alzheimer's disease
by: Justyna Gerłowska, et al.
Published: (2021-01-01)

Judgment in Mild Cognitive Impairment and Alzheimer's disease
by: Patrícia Helena Figueirêdo Vale Capucho, et al.

Increased prediction value of biomarker combinations for the conversion of mild cognitive impairment to Alzheimer’s dementia
by: Aonan Zhao, et al.
Published: (2020-08-01)

Dementia and Impairment, Directions for no specialist physicians
by: Archibaldo Donoso
Published: (2007-11-01)

Impact of Social Isolation on the Behavioral, Functional Profiles, and Hippocampal Atrophy Asymmetry in Dementia in Times of Coronavirus Pandemic (COVID-19): A Translational Neuroscience Approach
by: Aida Muntsant, et al.
Published: (2020-11-01)

Detection and recognition thresholds for five basic tastes in patients with mild cognitive impairment and Alzheimer’s disease dementia
by: Minoru Kouzuki, et al.
Published: (2020-03-01)

Erlangen Score as a tool to predict progression from mild cognitive impairment to dementia in Alzheimer’s disease
by: Inês Baldeiras, et al.
Published: (2019-01-01)

Performance of Mattis dementia rating scale-Chinese version in patients with mild cognitive impairment and Alzheimer’s disease
by: Shuxia Qian, et al.
Published: (2021-04-01)

Editorial: Neuroinflammatory response and brain-peripheral crosstalk after stroke
by: Devin W. McBride, et al.
Published: (2022-11-01)

A randomized, double‐blind, placebo‐controlled, parallel‐group 12‐week pilot phase II trial of SaiLuoTong (SLT) for cognitive function in older adults with mild cognitive impairment
by: Genevieve Z. Steiner‐Lim, et al.
Published: (2023-10-01)

An Ethnography Study of a Viral YouTube Educational Video in Ecuador: Dealing With Death and Grief in Times of COVID-19
by: Lydia Giménez-Llort, et al.
Published: (2021-07-01)

The Alzheimer’s Prevention Initiative Composite Cognitive Test: a practical measure for tracking cognitive decline in preclinical Alzheimer’s disease
by: Jessica B. Langbaum, et al.
Published: (2020-05-01)